ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILURE
- 9 July 1988
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 332 (8602), 72-74
- https://doi.org/10.1016/s0140-6736(88)90006-2
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 12 references indexed in Scilit:
- Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.The Journal of Experimental Medicine, 1987
- Preparation and Characterization of Monoclonal Antibodies Directed Against Antigenic Determinants of Recombinant Human Tumour Necrosis Factor (rTNF)Hybridoma, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression.JCI Insight, 1986
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Lymphokines and monokines in the clinicImmunology Today, 1986
- Endotoxemia in liver diseases: Detection by a quantitative assay using chromogenic substrate with perchloric acid pretreatment.Kanzo, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- ROLE OF MONONUCLEAR INFILTRATING CELLS IN PATHOGENESIS OF HEPATITISThe Lancet, 1978